• Kim Noonan, MS, RN, ANP, AOCN

     
    Yawkey Center for Cancer Care
     
    Lead Nurse Practitioner

    Center/Program

    Hematologic Oncology

    Phone: 617-582-7753
    Email: kimberly_noonan@dfci.harvard.edu

     
     

    Dana-Farber Cancer Institute
    450 Brookline Avenue
    Boston, MA 02215

    Background

    Education and Training
    Massachusetts Bay Community College, Associate of Science in Medical Technology, 1977
    UMass Boston, BSN, 1982
    Boston College, MS, Ambulatory Medical/Surgical Nursing, 1988

    Certification
    Advaned Oncology Certified Nurse (AOCN)

    Select Publications

    • Rogers, K.A. et al. (1992). Development and implementation of an oncology. Clinical Nurse Specialist Symptom Management service (abstract).  ONF 19(2) p. 310.
    • Singer, M & Noonan (Rogers), KA (1993). Continuous intravenous infusion of fentanyl:  Case reports of use in patients with advanced cancer and intractable pain.  Journal of Pain & Symptom Management, 8(4), P. 215-220.
    • Noonan, K. & Lacasse, C.  (1998). Quality of life during the first year after BMT:  A Qualitative analysis of the patient experience (Abstract).  ONF. 25(2) p. 315.
    • Maxwell, C, Swift, R & Noonan, K. (2001).  Convenience of a 15 minute infusion of Zoledronic Acid.  European Oncology Nursing Society (abstract).
    • Friedberg, J., Dong, D, Kim, H., Stephans, K., Noonan, K., Neuberg, D., (2004). Oral fludarabine has significant activity in patients with previously untreated CLL and leads to increased STAT 1  levels in vivo.  Leukemia Research, 28(2). Pp 139-147.
    • Noonan, K.  (2005).  The impact of chemotherapy-induced nausea and vomiting on the daily function and quality of life of patients.  Advanced Studies in Nursing. 3,(1), pp.  16-21.
    • Mulroney,T., Noonan, K., Tuscano, J. (2005). monograph, Monoclonal Antibodies:  Case studies in novel therapies for metastatic breast cancer and NHL.  OES, Pittsburgh, PA.
    • Boyajian, R. & Noonan, K. (2006).  Fractures. In D. Camp-Sorrell, & R. Hawkins (eds), Clinical Manual for the Oncology Advanced Practice Nurse (2nd ed).  pp. 733-738: Pittsburgh, Oncology Nursing Society.
    • Boyajian, R. & Noonan, K. (2006).  Gout.  In D. Camp-Sorrell, & R. Hawkins (eds), Clinical Manual for the Oncology Advanced Practice Nurse (2nd ed).  pp. 739-743: Pittsburgh, Oncology Nursing Society.
    • Boyajian, R. & Noonan, K. (2006).  Myalgias .  In D. Camp-Sorrell, & R. Hawkins (eds), Clinical Manual for the Oncology Advanced Practice Nurse (2nd ed).  pp. 723-732: Pittsburgh, Oncology Nursing Society.
    • Noonan, K. (2007). Introduction to B cell disorders.  Clinical Journal of Oncology Nursing. 11,(1), suppl.  pp. 3-12. 
    • Noonan, K. (2007).  Myeloma Messenger:  Turning point in the patient with relapsed multiple myeloma.  ONS Publication; Nov. 2007.
    • Noonan, K. (2010). Immunology. In J. Tariman (Ed.), Multiple Myeloma: A Textbook for Nurses: Pittsburgh, Oncology Nursing Society, 2010.
    • Noonan, K. (2010).  Pathophysiology.   In J. Tariman (Ed.), Multiple Myeloma: A Textbook for Nurses:  Pittsburgh, Oncology Nursing Society, 2010.